Proventil

Hyperkalemia, Acute Bronchitis, Pneumonia + 18 more

Treatment

9 FDA approvals

20 Active Studies for Proventil

What is Proventil

Salbutamol

The Generic name of this drug

Treatment Summary

Salbutamol is a medication used to treat asthma and COPD. It is designed to target the beta2-adrenergic receptors in the lungs, as opposed to beta1-adrenergic receptors located in the heart. Salbutamol is a mixture of two isomers, of which one is more effective and the other can be toxic. To avoid this issue, a single isomer version of the drug called levalbuterol was developed, but it is more expensive than salbutamol. Salbutamol is usually used for short-term relief of asthma symptoms, or as a preventative measure for

Proair HFA

is the brand name

image of different drug pills on a surface

Proventil Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Proair HFA

Salbutamol

1981

314

Approved as Treatment by the FDA

Salbutamol, also known as Proair HFA, is approved by the FDA for 9 uses like Chronic Obstructive Pulmonary Disease and Bronchospasm, Exercise-Induced .

Chronic Obstructive Pulmonary Disease

Used to treat Chronic Obstructive Pulmonary Disease (COPD) in combination with Ipratropium

Bronchospasm, Exercise-Induced

Bronchial Spasm

prophylaxis of Exercise-induced bronchospasm

Bronchospasm

Bronchodilator Agents

Used to treat need of more than one bronchodilator in combination with Ipratropium

Asthma, Exercise-Induced

prophylaxis of Bronchospasm

Exercise-Induced Bronchospasm

Effectiveness

How Proventil Affects Patients

Salbutamol (also known as albuterol) is a medicine used to open up breathing passages in people with asthma and other lung problems. It works by stimulating the beta-1 and beta-2 receptors in the body, which can cause increased heart rate, relaxed blood vessels, and muscle tremor. Taking salbutamol can also cause changes in blood sugar and insulin levels, and can lower potassium levels. The levalbuterol version of salbutamol is made from only the R-enantiomer and is believed to cause fewer side effects.

How Proventil works in the body

Salbutamol is a medication that relaxes the airways in the lungs, making it easier to breathe. It works by targeting and activating beta2-adrenergic receptors, which then triggers a series of reactions that lead to the relaxation of the smooth muscle in the airways. Salbutamol can also reduce inflammation in the airways by stopping the release of substances from mast cells. While it does affect heart rate and blood pressure, it does so less than other similar drugs. Salbutamol usually starts working within 5-15 minutes, and its effects last for 3-6 hours.

When to interrupt dosage

The suggested dosage of Proventil is contingent upon the determined condition, including Bronchodilator Agents, Emphysema and Wheezing. The amount of dosage is contingent upon the approach of administration outlined in the table below.

Condition

Dosage

Administration

prophylaxis of Bronchospasm

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Solution, Aerosol, metered, Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered, Spray, metered - Respiratory (inhalation), Inhalant, Nasal, Inhalant - Nasal, Inhalant - Respiratory (inhalation), Solution - Nasal, Spray, Spray - Oral, Powder, Powder - Respiratory (inhalation), Intravenous, Solution - Intravenous, Liquid - Intravenous, Aerosol, spray - Oral, Aerosol, spray, Aerosol, metered - Intrabronchial, Inhalant - Oral

Asthma

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Solution, Aerosol, metered, Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered, Spray, metered - Respiratory (inhalation), Inhalant, Nasal, Inhalant - Nasal, Inhalant - Respiratory (inhalation), Solution - Nasal, Spray, Spray - Oral, Powder, Powder - Respiratory (inhalation), Intravenous, Solution - Intravenous, Liquid - Intravenous, Aerosol, spray - Oral, Aerosol, spray, Aerosol, metered - Intrabronchial, Inhalant - Oral

Respiratory Tract Infections

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Solution, Aerosol, metered, Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered, Spray, metered - Respiratory (inhalation), Inhalant, Nasal, Inhalant - Nasal, Inhalant - Respiratory (inhalation), Solution - Nasal, Spray, Spray - Oral, Powder, Powder - Respiratory (inhalation), Intravenous, Solution - Intravenous, Liquid - Intravenous, Aerosol, spray - Oral, Aerosol, spray, Aerosol, metered - Intrabronchial, Inhalant - Oral

Acute Bronchitis

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Solution, Aerosol, metered, Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered, Spray, metered - Respiratory (inhalation), Inhalant, Nasal, Inhalant - Nasal, Inhalant - Respiratory (inhalation), Solution - Nasal, Spray, Spray - Oral, Powder, Powder - Respiratory (inhalation), Intravenous, Solution - Intravenous, Liquid - Intravenous, Aerosol, spray - Oral, Aerosol, spray, Aerosol, metered - Intrabronchial, Inhalant - Oral

Bronchitis, Chronic

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Solution, Aerosol, metered, Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered, Spray, metered - Respiratory (inhalation), Inhalant, Nasal, Inhalant - Nasal, Inhalant - Respiratory (inhalation), Solution - Nasal, Spray, Spray - Oral, Powder, Powder - Respiratory (inhalation), Intravenous, Solution - Intravenous, Liquid - Intravenous, Aerosol, spray - Oral, Aerosol, spray, Aerosol, metered - Intrabronchial, Inhalant - Oral

Asthma

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Solution, Aerosol, metered, Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered, Spray, metered - Respiratory (inhalation), Inhalant, Nasal, Inhalant - Nasal, Inhalant - Respiratory (inhalation), Solution - Nasal, Spray, Spray - Oral, Powder, Powder - Respiratory (inhalation), Intravenous, Solution - Intravenous, Liquid - Intravenous, Aerosol, spray - Oral, Aerosol, spray, Aerosol, metered - Intrabronchial, Inhalant - Oral

Influenza

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Solution, Aerosol, metered, Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered, Spray, metered - Respiratory (inhalation), Inhalant, Nasal, Inhalant - Nasal, Inhalant - Respiratory (inhalation), Solution - Nasal, Spray, Spray - Oral, Powder, Powder - Respiratory (inhalation), Intravenous, Solution - Intravenous, Liquid - Intravenous, Aerosol, spray - Oral, Aerosol, spray, Aerosol, metered - Intrabronchial, Inhalant - Oral

Bronchodilation

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Solution, Aerosol, metered, Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered, Spray, metered - Respiratory (inhalation), Inhalant, Nasal, Inhalant - Nasal, Inhalant - Respiratory (inhalation), Solution - Nasal, Spray, Spray - Oral, Powder, Powder - Respiratory (inhalation), Intravenous, Solution - Intravenous, Liquid - Intravenous, Aerosol, spray - Oral, Aerosol, spray, Aerosol, metered - Intrabronchial, Inhalant - Oral

Bronchial Spasm

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Solution, Aerosol, metered, Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered, Spray, metered - Respiratory (inhalation), Inhalant, Nasal, Inhalant - Nasal, Inhalant - Respiratory (inhalation), Solution - Nasal, Spray, Spray - Oral, Powder, Powder - Respiratory (inhalation), Intravenous, Solution - Intravenous, Liquid - Intravenous, Aerosol, spray - Oral, Aerosol, spray, Aerosol, metered - Intrabronchial, Inhalant - Oral

Emphysema

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Solution, Aerosol, metered, Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered, Spray, metered - Respiratory (inhalation), Inhalant, Nasal, Inhalant - Nasal, Inhalant - Respiratory (inhalation), Solution - Nasal, Spray, Spray - Oral, Powder, Powder - Respiratory (inhalation), Intravenous, Solution - Intravenous, Liquid - Intravenous, Aerosol, spray - Oral, Aerosol, spray, Aerosol, metered - Intrabronchial, Inhalant - Oral

Asthma, Exercise-Induced

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Solution, Aerosol, metered, Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered, Spray, metered - Respiratory (inhalation), Inhalant, Nasal, Inhalant - Nasal, Inhalant - Respiratory (inhalation), Solution - Nasal, Spray, Spray - Oral, Powder, Powder - Respiratory (inhalation), Intravenous, Solution - Intravenous, Liquid - Intravenous, Aerosol, spray - Oral, Aerosol, spray, Aerosol, metered - Intrabronchial, Inhalant - Oral

Pneumonia

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Solution, Aerosol, metered, Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered, Spray, metered - Respiratory (inhalation), Inhalant, Nasal, Inhalant - Nasal, Inhalant - Respiratory (inhalation), Solution - Nasal, Spray, Spray - Oral, Powder, Powder - Respiratory (inhalation), Intravenous, Solution - Intravenous, Liquid - Intravenous, Aerosol, spray - Oral, Aerosol, spray, Aerosol, metered - Intrabronchial, Inhalant - Oral

Bronchitis

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Solution, Aerosol, metered, Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered, Spray, metered - Respiratory (inhalation), Inhalant, Nasal, Inhalant - Nasal, Inhalant - Respiratory (inhalation), Solution - Nasal, Spray, Spray - Oral, Powder, Powder - Respiratory (inhalation), Intravenous, Solution - Intravenous, Liquid - Intravenous, Aerosol, spray - Oral, Aerosol, spray, Aerosol, metered - Intrabronchial, Inhalant - Oral

Airway secretion clearance therapy

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Solution, Aerosol, metered, Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered, Spray, metered - Respiratory (inhalation), Inhalant, Nasal, Inhalant - Nasal, Inhalant - Respiratory (inhalation), Solution - Nasal, Spray, Spray - Oral, Powder, Powder - Respiratory (inhalation), Intravenous, Solution - Intravenous, Liquid - Intravenous, Aerosol, spray - Oral, Aerosol, spray, Aerosol, metered - Intrabronchial, Inhalant - Oral

excess mucus or phlegm

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Solution, Aerosol, metered, Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered, Spray, metered - Respiratory (inhalation), Inhalant, Nasal, Inhalant - Nasal, Inhalant - Respiratory (inhalation), Solution - Nasal, Spray, Spray - Oral, Powder, Powder - Respiratory (inhalation), Intravenous, Solution - Intravenous, Liquid - Intravenous, Aerosol, spray - Oral, Aerosol, spray, Aerosol, metered - Intrabronchial, Inhalant - Oral

Hyperkalemia

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Solution, Aerosol, metered, Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered, Spray, metered - Respiratory (inhalation), Inhalant, Nasal, Inhalant - Nasal, Inhalant - Respiratory (inhalation), Solution - Nasal, Spray, Spray - Oral, Powder, Powder - Respiratory (inhalation), Intravenous, Solution - Intravenous, Liquid - Intravenous, Aerosol, spray - Oral, Aerosol, spray, Aerosol, metered - Intrabronchial, Inhalant - Oral

Asthma

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Solution, Aerosol, metered, Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered, Spray, metered - Respiratory (inhalation), Inhalant, Nasal, Inhalant - Nasal, Inhalant - Respiratory (inhalation), Solution - Nasal, Spray, Spray - Oral, Powder, Powder - Respiratory (inhalation), Intravenous, Solution - Intravenous, Liquid - Intravenous, Aerosol, spray - Oral, Aerosol, spray, Aerosol, metered - Intrabronchial, Inhalant - Oral

Respiratory Sounds

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Solution, Aerosol, metered, Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered, Spray, metered - Respiratory (inhalation), Inhalant, Nasal, Inhalant - Nasal, Inhalant - Respiratory (inhalation), Solution - Nasal, Spray, Spray - Oral, Powder, Powder - Respiratory (inhalation), Intravenous, Solution - Intravenous, Liquid - Intravenous, Aerosol, spray - Oral, Aerosol, spray, Aerosol, metered - Intrabronchial, Inhalant - Oral

Chronic Obstructive Pulmonary Disease

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Solution, Aerosol, metered, Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered, Spray, metered - Respiratory (inhalation), Inhalant, Nasal, Inhalant - Nasal, Inhalant - Respiratory (inhalation), Solution - Nasal, Spray, Spray - Oral, Powder, Powder - Respiratory (inhalation), Intravenous, Solution - Intravenous, Liquid - Intravenous, Aerosol, spray - Oral, Aerosol, spray, Aerosol, metered - Intrabronchial, Inhalant - Oral

Bronchospasm, Exercise-Induced

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Solution, Aerosol, metered, Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Liquid - Oral, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered, Spray, metered - Respiratory (inhalation), Inhalant, Nasal, Inhalant - Nasal, Inhalant - Respiratory (inhalation), Solution - Nasal, Spray, Spray - Oral, Powder, Powder - Respiratory (inhalation), Intravenous, Solution - Intravenous, Liquid - Intravenous, Aerosol, spray - Oral, Aerosol, spray, Aerosol, metered - Intrabronchial, Inhalant - Oral

Warnings

There are 20 known major drug interactions with Proventil.

Common Proventil Drug Interactions

Drug Name

Risk Level

Description

Hydroxyzine

Major

The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Hydroxyzine.

Mobocertinib

Major

The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Mobocertinib.

Ziprasidone

Major

The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Ziprasidone.

1-benzylimidazole

Minor

The risk or severity of hypertension can be increased when Salbutamol is combined with 1-benzylimidazole.

2,5-Dimethoxy-4-ethylamphetamine

Minor

The risk or severity of hypertension can be increased when Salbutamol is combined with 2,5-Dimethoxy-4-ethylamphetamine.

Proventil Toxicity & Overdose Risk

Taking too much albuterol can lead to side effects like rapid breathing, high or low blood pressure, a fast heartbeat, shaking, headaches, dry mouth, nausea, dizziness, fatigue, difficulty sleeping, elevated blood sugar levels, low levels of potassium, and acid buildup in the body. Albuterol should be used with caution during pregnancy and should not be used while breastfeeding. It is not recommended for children under 4 years old. The most toxic dose of albuterol was found to be 1100mg/kg in mice.

image of a doctor in a lab doing drug, clinical research

Proventil Novel Uses: Which Conditions Have a Clinical Trial Featuring Proventil?

Condition

Clinical Trials

Trial Phases

prophylaxis of Bronchospasm

0 Actively Recruiting

Influenza

28 Actively Recruiting

Not Applicable, Phase 3, Phase 4, Phase 2, Phase 1

Asthma

97 Actively Recruiting

Phase 1, Phase 4, Not Applicable, Early Phase 1, Phase 2, Phase 3

Chronic Obstructive Pulmonary Disease

77 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Phase 3, Phase 4

Bronchospasm, Exercise-Induced

0 Actively Recruiting

Hyperkalemia

4 Actively Recruiting

Phase 3, Phase 2, Phase 1, Not Applicable

Bronchitis, Chronic

6 Actively Recruiting

Phase 2, Not Applicable, Phase 4

excess mucus or phlegm

0 Actively Recruiting

Bronchodilator Agents

0 Actively Recruiting

Pneumonia

18 Actively Recruiting

Not Applicable, Phase 2, Early Phase 1, Phase 4

Bronchial Spasm

0 Actively Recruiting

Asthma

10 Actively Recruiting

Phase 2, Not Applicable

Airway secretion clearance therapy

0 Actively Recruiting

Respiratory Sounds

0 Actively Recruiting

Asthma

1 Actively Recruiting

Phase 4

Asthma, Exercise-Induced

0 Actively Recruiting

Emphysema

6 Actively Recruiting

Phase 2, Not Applicable, Early Phase 1

Bronchitis

0 Actively Recruiting

Acute Bronchitis

6 Actively Recruiting

Not Applicable, Phase 3, Early Phase 1, Phase 4

Bronchodilation

0 Actively Recruiting

Proventil Reviews: What are patients saying about Proventil?

5

Patient Review

7/21/2011

Proventil for Chronic Obstructive Lung Disease

I've been using this medicine for two weeks and, unfortunately, find that I need it more frequently to relieve my breathing. Additionally, I now have muscle cramps in my lower leg--a side effect of the medication. I'm going to ask the doctor if there's anything else I can take to help with my asthma.

4.7

Patient Review

8/13/2010

Proventil for Bronchitis

4.7

Patient Review

6/6/2012

Proventil for Asthma

I began this treatment recently and it has already had a positive effect on my wheezing and breathing.

4.3

Patient Review

6/9/2013

Proventil for Chronic Obstructive Lung Disease

This medication provides me with much needed relief from my shortness of breath.

4.3

Patient Review

7/14/2012

Proventil for Asthma

I've used this for approximately six months. It may be losing its efficacy; it used to last six hours but now only lasts four. I also tried Qvar and Singulair, neither of which had any impact whatsoever. Proventil is effective, though not as quick-acting as the old albuterol.

4.3

Patient Review

4/4/2015

Proventil for Bronchitis

I find it difficult to tell when the medication is running low; a counter on the device would be helpful for this. Despite that, it's been effective in helping me manage bronchitis.

4

Patient Review

6/3/2013

Proventil for Obstructive Pulmonary Disease

I'm not sure if this is the same as Ventolin HFA, but it worked well for me.

4

Patient Review

11/18/2011

Proventil for Bronchospasm Prevention

My doctor gave me this inhaler to help with my shortness of breath that is caused by anxiety. However, I haven't found it to be effective at all.

3

Patient Review

2/18/2011

Proventil for Asthma

This inhaler is a lifesaver! I was using regular albuteral before and it almost landed me in the hospital. This inhaler helped immediately and I can finally breathe freely again. It's an amazing feeling!

2.7

Patient Review

8/11/2010

Proventil for Asthma

2.7

Patient Review

12/23/2014

Proventil for Asthma Attack

The worst part about using rescue inhalers is the lack of confidence in their effectiveness.

2.3

Patient Review

10/29/2010

Proventil for Asthma

2.3

Patient Review

12/27/2012

Proventil for Chronic Obstructive Lung Disease

The taste is really bad, and I don't think it's as effective as Ventolin.

2.3

Patient Review

9/10/2014

Proventil for Asthma

One of the worst things about this inhaler is that there's no counter, so you can't tell how many doses are left. This makes it really difficult to plan ahead and know when you need to get a new one. I just took two puffs, but now I have no idea if there's anything left in the canister. I had to call my doctor for a new script, just in case.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about proventil

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is albuterol and Proventil the same thing?

"The brand names for albuterol inhalers include Ventolin HFA, ProAir HFA, Proventil HFA, and ProAir RespiClick. These four medications come in an L-shaped inhaler."

Answered by AI

What is Proventil used for?

"Albuterol is used to treat and prevent wheezing and shortness of breath caused by breathing problems such as asthma and chronic obstructive pulmonary disease. Exercise-induced asthma can also be treated with albuterol. The drug provides quick relief."

Answered by AI

Why is Proventil no longer available?

"Merck has stopped making Proventil HFA inhalers and Par has stopped making albuterol HFA inhalers. Perrigo has also stopped making albuterol HFA 8.5 gram inhalers. This is because there was a problem with the inhalers getting blocked, which the company discovered in September 2020."

Answered by AI

Is Proventil inhaler a steroid?

"Do steroids come in Ventolin?

No, Ventolin does not contain steroids."

Answered by AI

Clinical Trials for Proventil

Image of Allergy and Clinical Immunology Associates in Pittsburgh, United States.

Tilrekimig for Asthma

12 - 80
All Sexes
Pittsburgh, PA

The purpose of this clinical study is to learn about the safety and effects of the study medicine (called tilrekimig) for the potential treatment of severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life of people who are affected. The study is seeking participants who: * Have a history of severe asthma for at least 12 months * Have had at least 2 asthma attacks (also known as exacerbations) within the last 12 months All participants will be given shots of study medicine or a placebo at the study clinic. Tilrekimig or the placebo will be given about every 4 weeks during the study. The study will compare the experiences of people receiving tilrekimig to those people who receive the placebo. This will help determine if tilrekimig is safe and effective.

Phase 3
Recruiting

Allergy and Clinical Immunology Associates (+2 Sites)

Pfizer CT.gov Call Center

Pfizer

Image of Seattle Children's Hospital in Seattle, United States.

Follow-Up Strategies for Children With Medical Complexity

1 - 16
All Sexes
Seattle, WA

Children with medical complexity often receive a recommendation to see an outpatient clinician soon after leaving the hospital. It is uncertain whether every child needs this routine visit or whether follow-up can be guided by the family's concerns and the child's recovery. AFTERCARE is a multicenter pilot randomized trial comparing these two follow-up recommendations for children hospitalized with an acute infection. Families will be assigned by chance to receive either a recommendation to arrange follow-up with their usual outpatient clinician within seven days or a recommendation to seek follow-up if the child is not improving as expected or new concerns arise. Families in both groups may seek medical care whenever needed. The study will assess recruitment, follow-up data collection, delivery of the recommendations and acceptability. Caregiver surveys and medical record review will also describe outpatient visits and hospital returns. This pilot will inform the design of a larger trial, and is not designed to establish that the strategies are equally safe or effective.

Waitlist Available
Has No Placebo

Seattle Children's Hospital

Nassr Nama, MD, MSc

Have you considered Proventil clinical trials?

We made a collection of clinical trials featuring Proventil, we think they might fit your search criteria.
Go to Trials
Image of Rocky Mountain Regional VA Medical Center, Aurora, CO in Aurora, United States.

Low-Dose CT for Lung Cancer Screening

50 - 80
All Sexes
Aurora, CO

Lung cancer screening with low-dose chest computed tomography (CT) is currently recommended for high-risk individuals who are 50 to 80 years old, have smoked cigarettes for at least 20 pack-years, and currently smoke or quit smoking within the past 15 years. In a prospective cohort at Nashville, Denver, Louisville, Chicago, Kansas City, Salisbury and Seattle Veteran Affairs medical centers, the investigators will evaluate the detection of lung cancer using an expanded screening eligibility criteria based on Veterans' personal and service-related exposures compared to standard of care criteria. Screening a larger population will increase the number of lung nodules needing clinical management and these nodules may or may not be cancer. In a population of Veterans with positive screenings at Nashville, the investigators will also validate a combination biomarker-based approach to manage screen-detected lung nodules to reduce time to lung cancer diagnosis and use of invasive procedures. This study will also convene a Veteran Community Advisory Board and interview Veterans to better understand their thoughts about lung cancer screening and preferences for outreach and engagement.

Waitlist Available
Has No Placebo

Rocky Mountain Regional VA Medical Center, Aurora, CO (+6 Sites)

Jennifer A Lewis, MD MS MPH

Bristol-Myers Squibb

Image of Emory University Hospital (EUH) in Atlanta, United States.

Influenza Transmission Study

18 - 49
All Sexes
Atlanta, GA

The purpose of this study is to determine whether influenza A or B can be transmitted from adults with naturally acquired community influenza infection to healthy adult recipients under controlled inpatient exposure conditions, and to identify donor, recipient, viral, immunologic, behavioral, and environmental factors associated with transmission. This study differs from a traditional influenza CHIM because no challenge stock will be administered. Instead, naturally infected community donors will serve as the source of exposure. This approach is intended to better reflect naturally circulating influenza viruses and naturally infected donors while preserving the safety advantages of inpatient monitoring, defined exposure windows, controlled environmental measurements, and standardized sampling.

Waitlist Available
Has No Placebo

Emory University Hospital (EUH) (+1 Sites)

Nadine Rouphael, MD, MSc

Have you considered Proventil clinical trials?

We made a collection of clinical trials featuring Proventil, we think they might fit your search criteria.
Go to Trials
Image of SMS Clinical Research LLC in Garland, United States.

Tilrekimig for Severe Asthma

12 - 80
All Sexes
Garland, TX

The purpose of this clinical study is to learn about the safety and effects of the study medicine (called tilrekimig) for the potential treatment of severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life of people who are affected. The study is seeking participants who: * Have a history of severe asthma for at least 12 months * Have had at least 2 asthma attacks (also known as exacerbations) within the last 12 months All participants will be given shots of study medicine or a placebo at the study clinic. The study will compare the experiences of people receiving tilrekimig to those people who receive the placebo. This will help determine if tilrekimig is safe and effective.

Phase 3
Recruiting

SMS Clinical Research LLC (+6 Sites)

Pfizer CT.gov Call Center

Pfizer

Image of St. Michael's Hospital (Unity Health Toronto) in Toronto, Canada.

Treatment for Hyperkalemia

18+
All Sexes
Toronto, Canada

People with end-stage kidney disease who receive hemodialysis are often told to strictly limit foods high in potassium, such as fruits, vegetables, legumes, nuts, and whole grains. This advice is intended to prevent high blood potassium levels (hyperkalemia), which can cause dangerous heart rhythm problems. However, these restrictions can make eating difficult, reduce diet quality, and lower quality of life. New research suggests that not all sources of potassium affect the body in the same way. Potassium added to highly processed foods is more easily absorbed than potassium naturally found in whole foods like fruits and vegetables. Large studies have found little evidence that eating potassium-rich whole foods increases blood potassium levels in people on dialysis. Clinical guidelines are beginning to shift, but no high-quality clinical trial has tested whether a more flexible, food-based approach is safe for people receiving hemodialysis. This study will compare two dietary approaches in 148 adults on hemodialysis: the usual low potassium diet and a "liberalized" potassium diet that encourages minimally processed foods while limiting highly processed foods with potassium additives. Participants will receive dietitian support and grocery assistance for 12 weeks. The investigators will closely monitor blood potassium levels to ensure safety. The investigators will also examine whether the liberalized diet is as safe as standard care, and whether it improves diet quality and quality of life. The investigators will also study factors that influence the participant's ability to follow the diet in real-world settings. If safe, this approach could reduce unnecessary food restrictions, improve diet quality, and enhance quality of life for people receiving hemodialysis, while maintaining patient safety.

Waitlist Available
Has No Placebo

St. Michael's Hospital (Unity Health Toronto)

JoAnne Arcand, PhD, RD

Have you considered Proventil clinical trials?

We made a collection of clinical trials featuring Proventil, we think they might fit your search criteria.
Go to Trials